About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

378040 studies
in
220 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 06/15/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 06/15/2021.

Noise in the Intensive Care Care Unit and Its Influence on Cortical Arousals and Sleep Phases

Clinicaltrials.gov identifier NCT03942393

Recruitment Status Completed

First Posted May 8, 2019

Last update posted May 9, 2019

Study Description

Brief summary:

This is a prospective observational study in an Italian general-neurologic ICU. Sleep was monitored during the night, using a simplified polysomnography(PSG), for a maximum of five consecutive nights. Adults patients were eligible for the study if they remained in the ICU for at least 24 hours

  • Condition or Disease:Sleep Phase Rhythm Disturbance
  • Intervention/Treatment:
  • Phase: N/A
Detailed Description

This is a prospective observational study conducted from April 2016 to October 2017 in the general-neurologic ICU In a university-affiliated hospital serving a population of 1 million habitant in the north-east of Italy. Patients were considered eligible if they were older than 18 and remained in the ICU for at least 24 hours. Patients with anamnestic severe dementia, severely decreased mental state defined as Richmond Agitation-Sedation Scale (RASS) lower than -3, and language barrier were excluded. Patients coming from other hospitals were excluded, because they might have been treated with long-lasting sleep or sedative drugs, which could deeply modify sleep quality. Patients needing continuous infusion of sedative drugs were also excluded since this could interfere with the interpretation of PSG data. Finally, patients with frontal wounds, brain lesions in the frontal lobes, external ventricular drainage and noninvasive mechanical ventilation were excluded because of the impossibility to position the PSG device. The study was conducted in accordance with the Declaration of Helsinki and was approved by the local Ethics Committee of Brescia (NP 23332). Patients' informed consent was waived due to the lack of definition of a legal representative of temporarily incapacitated adult patients in the Italian legislation. The informed consent was obtained from the surviving patients as soon as they regained their mental competency. Family members received detailed information on the study scope and protocol. . Sleep was monitored using a simplified PSG, Sleep Profiler (Advanced Brain Monitoring) with the device placed by the nursing staff, from 10:00 pm to 7:00 am, for a minimum of one night to a maximum of five consecutive nights . In case of occurrence of any of the exclusion criteria, such as positioning of external ventricular drainage, the PSG monitoring was interrupted. The authors collected data on age, sex, the Simplified Acute Physiology Score (SAPS II) reason for ICU admission, length of ICU stay, and presence of delirium, assessed three times daily using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Any administration of drugs that could influence sleep were also recorded, including benzodiazepine as anxiolytics, opioids, dexmedetomidine, zolpidem, and melatonin. The Sleep Profiler consists of a band with three channels for EEG, one channel for the electromyography of the masseter muscle (a touch proof connector with two electrodes), a plethysmography for heart rate, a microphone to register both ICU noise and patient snoring, and a 3D accelerometer to record head movements23. The registered parameters were then analyzed by a software that identifies sleep stages and Cortical Arousals (CA), and a report was generated for each night. The authors analyzed the association of nocturnal noise, defined as the percentage of Total Sleep Time (TST) during which noise exceeds 40 decibel (dB), with duration of Rapid Eye Movement (REM )and Slow Wave Sleep (SWS) phases, expressed as a percentage of TST, and number of CAs. STATISTICAL ANALYSIS Characteristics of the study population were summarized as number (percentage) for binary variables, and as mean (standard deviation, SD) or median (interquartile range, IQR), as appropriate, for continuous variables. The study outcomes were duration of the REM and SWS stages and number of CAs, all analyzed as binary variables: REM: 0% or > 0% of the TST; SWS: ≤9% or > 9% of TST (threshold previously used in the literature24,25); CAs: ≤43 or >43 CAs per hour (threshold corresponding to the median value in our ICU, in the absence of information from the literature). The association of noise with REM, SWS and CAs was analyzed using mixed-effect logistic regression models for repeated measures (measurements over nights for each patient), adjusting for SAPS II, age and sex as potential confounders. A sensitivity analysis were also performed in which further adjustment for the administration of drugs influencing sleep were added. Results are presented as odds ratio (OR) and 95% confidence interval (95% CI). All statistical analyses were performed using STATA (Stata Corp, Texas, USA).

Study Design
  • Study Type: Observational
  • Actual Enrollment: 40 participants
  • Observational Model: Cohort
  • Time Perspective: Prospective
  • Official Title: Noise in the Intensive Care Care Unit and Its Influence on Cortical Arousals: a Prospective Cohort Study
  • Actual Study Start Date: April 2016
  • Actual Primary Completion Date: September 2017
  • Actual Study Completion Date: September 2017
Outcome Measures
  • Primary Outcome Measures: 1. Number of cortical arousals per hour [ Time Frame: Up to 5 consecutive nights from 10:00 pm to 7:00 am ]
    analyzed as binary variables:< 43 or > 43per hour regression
  • Secondary Outcome Measures: 1. presence of REM phases [ Time Frame: Up to 5 consecutive nights from 10:00 pm to 7:00 am ]
    analyzed as binary variables:0% or > 0% of Total sleep time
  • 2. Duration of SWS phases [ Time Frame: Up to 5 consecutive nights from 10:00 pm to 7:00 am ]
    analyzed as binary variables: < 9% or > 9% of Total Sleep Time
Eligibility Criteria
  • Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: No
  • Sampling Method: Probability Sample
  • Study Population: All critically Ill patients recovered in intensive care unit non comatose whith a waking sleep rhythm
Criteria

Inclusion Criteria:

- older than 18

- recovered in ICU

- remained in the ICU for at least 24 hours.

Exclusion Criteria:

- patients with anamnestic severe dementia

- patients with severely decreased mental state (defined as Richmond Agitation-Sedation
Scale, RASS, lower than -3)

- presence of language barrier

- patients coming from other hospitals

- patients needing continuous infusion of sedative drugs

- patients with frontal wounds, brain lesions in the frontal lobes, external ventricular
drainage and noninvasive mechanical ventilation were excluded because of the
impossibility to position the PSG device

Contacts and Locations
Contacts
Locations

Italy
Spedali Civili, Anestesia e Rianimazione 2
Brescia

Sponsors and Collaborators

Università degli Studi di Brescia

Investigators

Principal Investigator: ELISA SEGHELINI II Servizio Rianimazione,, Spedali Civili Brescia

More Information
  • Responsible Party: Università degli Studi di Brescia
  • ClinicalTrials.gov Identifier: NCT03942393 History of Changes
  • Other Study ID Numbers: NP23332
  • First Posted: May 8, 2019 Key Record Dates
  • Last Update Posted: May 9, 2019
  • Last Verified: May 2019
  • Individual Participant
    Data (IPD) Sharing
    Statement:
  • Plan to Share IPD: No
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No
  • Keywords provided by Università degli Studi di Brescia: noise
    sleep quality
    polysomnography
    cortical arousals
    REM sleep
    Intensive Care Unit